Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice

被引:0
作者
Verel, I
Visser, GWM
Boellaard, R
Boerman, OC
van Eerd, J
Snow, GB
Lammertsma, AA
van Dongen, GAMS
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Radionuclide Ctr, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, PET Ctr, Amsterdam, Netherlands
[4] Univ Med Ctr Nijmegen, Dept Nucl Med, Nijmegen, Netherlands
关键词
Zr-89; PET; monoclonal antibodies; xenograft-bearing nude mice; Y-90;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor targeting and the accurate estimation of radiation dose delivery to both tumor and normal tissues. Immuno-PET with Zr-89-labeled monoclonal antibodies (mAbs) and Y-90-mAb RIT might form such a valuable combination. In this study, the biodistribution of Zr-89-labeled and Y-88-labeled mAb (Y-88 as substitute for Y-90) was compared and the quantitative imaging performance of Zr-89 immuno-PET was evaluated. Methods: Chimeric mAb (cmAb) U36, directed against an antigen preferentially expressed in head and neck cancer, was labeled with Zr-89 using the bifunctional chelate N-succinyldesferrioxamine B (N-sucDf) and with Y-88 using the bifunctional chelate p-isothiocyanatobenzyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (p-SCN-Bz-DOTA). The radioimmunoconjugates were coinjected in xenograft-bearing nude mice, and biodistribution was determined at 3, 24, 48, 72, and 144 h after injection. Zr-89 was evaluated and compared with F-18 in phantom studies to determine linearity, resolution, and recovery coefficients, using a high-resolution research tomograph PET scanner. The potential of PET to quantify cmAb U36-N-sucDf-Zr-89 was evaluated by relating image-derived tumor uptake data (noninvasive method) to Zr-89 uptake data derived from excised tumors (invasive method). Results: Zr-89-N-sucDf-labeled and Y-88-p-SCN-Bz-DOTA-labeled cmAb U36 showed a highly similar biodistribution, except for sternum and thighbone at later time points (72 and 144 h after injection). Small differences were found in kidney and liver. Imaging performance of Zr-89 approximates that of F-18, whereas millimeter-sized (19-154 mg) tumors were visualized in xenograft-bearing mice after injection of cmAb U36-N-sucDf-Zr-89. After correction for partial-volume effects, an excellent correlation was found between image-derived Zr-89 tumor radioactivity and gamma-counter Zr-89 values of excised tumors (R-2 = 0.79). Conclusion: The similar biodistribution and the favorable imaging characteristics make Zr-89 a promising candidate for use as a positron-emitting surrogate for Y-90.
引用
收藏
页码:1663 / 1670
页数:8
相关论文
共 24 条
[1]  
Bethesda MD, 1985, NIH PUBLICATION, V86-23
[2]   Characterization of a single LSO crystal layer high resolution research tomograph [J].
Boellaard, R ;
Buijs, F ;
de Jong, HWAM ;
Lenox, M ;
Gremillion, T ;
Lammertsma, AA .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (04) :429-448
[3]  
Carrasquillo JA, 1999, J NUCL MED, V40, P268
[4]   A new era for radiolabeled antibodies in cancer? [J].
DeNardo, SJ ;
Kroger, LA ;
DeNardo, GL .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (05) :563-569
[5]  
Eary JF, 2001, J NUCL MED, V42, P770
[6]   A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™ [J].
Garmestani, K ;
Milenic, DE ;
Plascjak, PS ;
Brechbiel, MW .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (05) :599-606
[7]   Recovery correction for quantitation in emission tomography: a feasibility study [J].
Geworski, L ;
Knoop, BO ;
de Cabrejas, ML ;
Knapp, WH ;
Munz, DL .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (02) :161-169
[8]  
HERZOG H, 1993, J NUCL MED, V34, P2222
[9]   THE PREPARATION OF DTPA-COUPLED ANTIBODIES RADIOLABELED WITH METALLIC RADIONUCLIDES - AN IMPROVED METHOD [J].
HNATOWICH, DJ ;
CHILDS, RL ;
LANTEIGNE, D ;
NAJAFI, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) :147-157
[10]   DETERMINATION OF THE IMMUNOREACTIVE FRACTION OF RADIOLABELED MONOCLONAL-ANTIBODIES BY LINEAR EXTRAPOLATION TO BINDING AT INFINITE ANTIGEN EXCESS [J].
LINDMO, T ;
BOVEN, E ;
CUTTITTA, F ;
FEDORKO, J ;
BUNN, PA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 72 (01) :77-89